Supplier🇩🇪 GermanyDE119426029
Octapharma GmbH
Tenders published
0
Contracts won
29
Value won (EUR)
€216k
Latest contracts won
AwardedHealth & social care🇩🇪 GermanyTED
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zu den Wirkstoffen Wirkstoffen Blutgerinnungsfaktor VII, IX, Simoctocog alfa sowie von Willebrand-Faktor und Blutgerinnungsfaktor VIII in Kombination
AOK Baden-Württemberg
Estimated value
€216k
Won €216,000 · 1 tenders received
AwardedHealth & social care🇩🇪 GermanyTED
Arzneimittelvergaben Blutprodukte zum 01.01.2027
PBMG eG
Published 17 Sept 2026
11 lots won · 1 tenders received
AwardedHealth & social care🇩🇪 GermanyTED
Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Nuwiq (B02BD02), Octanate (B02BD02), Octanine F (B02BD04) und Wilate (B02BD06) bei Hämophilie
AOK Sachsen - Anhalt
Published 3 Sept 2026
Won €1 · 1 tenders received
AwardedHealth & social care🇩🇪 GermanyTED
Arzneimittelvergaben / Blutprodukte zum 1.Januar 2026
PBMG eG
Published 2 Mar 2026
10 lots won · 1 tenders received
AwardedHealth & social care🇩🇪 GermanyTED
Arzneimittelvergaben / Blutprodukte zum 1.Januar 2025
PBMG eG
Published 2 Sept 2024
6 lots won · 3 tenders received
Usual buyers
- 🇩🇪 PBMG eG27 awards
- 🇩🇪 AOK Baden-Württemberg1 award · €216k
- 🇩🇪 AOK Sachsen - Anhalt1 award
Sectors
- Health & social care29
By year
- 20246
- 202623